L4 VASOACTIVE DRUGS - DR - Yagub S Saleh
L4 VASOACTIVE DRUGS - DR - Yagub S Saleh
L4 VASOACTIVE DRUGS - DR - Yagub S Saleh
Yagub S Saleh
Dep. of Pharmacology 2023-2024
VASOACTIVE DRUGS
Vasoconstrictor drugs
Vasodilator drugs
Vasoconstrictor drugs
Direct acting:
Alpha1 adrenoceptor agonists
Indirect acting:
Drugs that release noradrenalin from sympathetic nerve terminals or inhibit its
reuptake
Some eicosanoids :
Thromboxane A2
Peptides:
Endothelin, angiotensin and antidiuretic hormone
Ergot alkaloids:
Sumatriptan acting through 5-HT type 2 receptor
Clinical uses of vasoconstrictor drugs
1. Local applications (nasal decongestion)
2. Coadministration with local anaesthetics
3. Adrenaline in anaphylactic shock and in cardiac arrest
4. Antidiuretic hormone to stop bleeding from oesophageal varices in patients with portal
hypertension caused by liver disease
Vasodilators drugs
Vasodilators action:
Increase local tissue blood flow
Reduce arterial pressure
Reduce central venous pressure
Net effects are
Reduction of cardiac pre-load (reduced filling pressure)
Reduction of after-load (reduced vascular resistance)
The net result is reduction of cardiac work
Calcium Antagonists
Block directly voltage-dependent calcium channels & cause generalised arterial vasodilation.
Amlodipine: Similar to nifedipine except much longer t 1/2 (40h) permitting the same benefits
as the longest-acting formulations of nifedipine without requiring a special formulation.
Drugs that act via cyclic nucleotides and enzymes by increasing cAMP or cGMP
Nitric oxide (NO), nitrates and the natriuretic peptides act through cGMP
Dopamin increases cAMP by activating adenylate cyclase
Nitroprusside (i.v.)
Yields NO, acts equally on arterial and venous smooth muscle
t1/2 is only few minutes, it must be given as a continuous infusion with careful monitoring
to avoid hypotension.
Usage:
In intensive care units for hypertensive crises
To produce controlled hypotension during surgery
Phosphodiesterase inhibitors
Methylxanthines: Theophylline
Exert their main effects on extravascular smooth muscle
Papaverine
Vasodilator of blood vessels (cerebral and coronary vasodilator)
Sildenafil (Viagra) inhibits the breakdown of cGMP. Increases penile erection
ET-1 in the heart causes SR release of calcium, which increases contractility. ET-1 also
increases heart rate.
One endothelin receptor antagonist has been approved. Bosentan, a non-selective ET-1 receptor
antagonist (blocks ETA and ETB receptors) is currently used in the treatment of pulmonary
hypertension.
Renin Inhibitors
Aliskiren is a renin inhibitor that was approved for the treatment of hypertension by the U.S.
FDA in 2007